Lucid Diagnostics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -18.0% | +17.5% | +6.4% | -33.8% | +35.9% | +6.8% | +17.9% | +37.6% | -24.0% | -15.7% | +14.3% | |
| – | -19.2% | +25.0% | +1.3% | -39.8% | +49.5% | +9.5% | +22.9% | +47.3% | -24.8% | -16.3% | +16.8% | |
| – | -21.4% | +31.1% | +0.6% | -41.9% | +54.3% | +12.9% | +23.3% | +52.1% | +73,222.5% | -99.9% | +19.8% | |
| – | -21.4% | +31.1% | +0.6% | -41.9% | +54.3% | +12.9% | +23.3% | +52.1% | +73,222.5% | -99.9% | +19.8% | |
| – | +114.3% | +8.9% | +226.5% | -75.6% | +938.5% | -84.9% | +511.5% | +47.5% | +16.9% | +7.2% | +57.9% | |
| – | +46.3% | +47.5% | +66.6% | -4.7% | -47.6% | +41.9% | +102.7% | -12.7% | +41,138.3% | -99.7% | -51.6% | |
| – | -26.2% | -26.1% | -10.0% | -11.1% | -12.6% | -14.3% | -16.6% | -20.0% | +74,721.9% | -99.9% | -50.0% | |
| – | -3.6% | -31.9% | -10.0% | -10.3% | +55.7% | +50.7% | -19.3% | -11.2% | +7.8% | +1.9% | -6.9% | |
| – | -2.8% | -32.0% | -20.0% | -10.8% | +65.1% | +55.5% | -19.5% | -10.9% | +9.1% | +2.8% | -6.4% | |
| – | -3.6% | -7.0% | -13.7% | -8.5% | +76.0% | +73.1% | -22.3% | -11.4% | +7.4% | +4.9% | -6.5% | |
| – | +15.3% | -15.4% | -6.8% | +25.7% | +9.3% | -33.2% | +0.5% | -9.8% | +29.2% | +11.0% | -38.1% | |
| – | -190.4% | – | +34.3% | -60.3% | -14.9% | -199.7% | – | +228.6% | -57.7% | -63.4% | +173.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.3% | +7.8% | +7.1% | +4.5% | +14.6% | +19.2% | +43.9% | +9.3% | -5.8% | +0.0% | +79.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.